161 related articles for article (PubMed ID: 21997859)
1. Analysis of volatile fingerprints for monitoring anti-fungal efficacy against the primary and opportunistic pathogen Aspergillus fumigatus.
Pont NP; Kendall CA; Magan N
Mycopathologia; 2012 Mar; 173(2-3):93-101. PubMed ID: 21997859
[TBL] [Abstract][Full Text] [Related]
2. Aspergillus fumigatus Transcription Factors Involved in the Caspofungin Paradoxical Effect.
Valero C; Colabardini AC; Chiaratto J; Pardeshi L; de Castro PA; Ferreira Filho JA; Silva LP; Rocha MC; Malavazi I; Costa JH; Fill T; Barros MH; Wong SSW; Aimanianda V; Wong KH; Goldman GH
mBio; 2020 Jun; 11(3):. PubMed ID: 32546620
[No Abstract] [Full Text] [Related]
3. Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus.
Lamoth F; Juvvadi PR; Steinbach WJ
Crit Rev Microbiol; 2016; 42(2):310-21. PubMed ID: 25243616
[TBL] [Abstract][Full Text] [Related]
4. Phosphoproteomics of Aspergillus fumigatus Exposed to the Antifungal Drug Caspofungin.
Mattos EC; Palmisano G; Goldman GH
mSphere; 2020 May; 5(3):. PubMed ID: 32461274
[No Abstract] [Full Text] [Related]
5. Screening method to identify inhibitors of siderophore biosynthesis in the opportunistic fungal pathogen, Aspergillus fumigatus.
Pinto LJ; Moore MM
Lett Appl Microbiol; 2009 Jul; 49(1):8-13. PubMed ID: 19453952
[TBL] [Abstract][Full Text] [Related]
6. Volatile Compounds Emitted by Pseudomonas aeruginosa Stimulate Growth of the Fungal Pathogen Aspergillus fumigatus.
Briard B; Heddergott C; Latgé JP
mBio; 2016 Mar; 7(2):e00219. PubMed ID: 26980832
[TBL] [Abstract][Full Text] [Related]
7. Sniffing out the hypoxia volatile metabolic signature of Aspergillus fumigatus.
Rees CA; Stefanuto PH; Beattie SR; Bultman KM; Cramer RA; Hill JE
J Breath Res; 2017 Aug; 11(3):036003. PubMed ID: 28825403
[TBL] [Abstract][Full Text] [Related]
8. Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis.
Alanio A; Denis B; Hamane S; Raffoux E; Peffault de Latour R; Menotti J; Amorim S; Touratier S; Bergeron A; Bretagne S
Emerg Infect Dis; 2016 Jan; 22(1):157-8. PubMed ID: 26690934
[No Abstract] [Full Text] [Related]
9. Anti-melanogenic activity of Myristica fragrans extract against Aspergillus fumigatus using phenotypic based screening.
Hoda S; Vermani M; Joshi RK; Shankar J; Vijayaraghavan P
BMC Complement Med Ther; 2020 Mar; 20(1):67. PubMed ID: 32122336
[TBL] [Abstract][Full Text] [Related]
10. Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus.
Dannaoui E; Garcia-Hermoso D; Naccache JM; Meneau I; Sanglard D; Bouges-Michel C; Valeyre D; Lortholary O
J Med Microbiol; 2006 Oct; 55(Pt 10):1457-1459. PubMed ID: 17005798
[TBL] [Abstract][Full Text] [Related]
11. Erg4A and Erg4B Are Required for Conidiation and Azole Resistance via Regulation of Ergosterol Biosynthesis in Aspergillus fumigatus.
Long N; Xu X; Zeng Q; Sang H; Lu L
Appl Environ Microbiol; 2017 Feb; 83(4):. PubMed ID: 27986720
[TBL] [Abstract][Full Text] [Related]
12. Antifungal activity of essential oils and their synergy with fluconazole against drug-resistant strains of Aspergillus fumigatus and Trichophyton rubrum.
Khan MS; Ahmad I
Appl Microbiol Biotechnol; 2011 May; 90(3):1083-94. PubMed ID: 21336686
[TBL] [Abstract][Full Text] [Related]
13. The quinoline bromoquinol exhibits broad-spectrum antifungal activity and induces oxidative stress and apoptosis in Aspergillus fumigatus.
Ben Yaakov D; Shadkchan Y; Albert N; Kontoyiannis DP; Osherov N
J Antimicrob Chemother; 2017 Aug; 72(8):2263-2272. PubMed ID: 28475687
[TBL] [Abstract][Full Text] [Related]
14. A Unique Dual-Readout High-Throughput Screening Assay To Identify Antifungal Compounds with Aspergillus fumigatus.
Beattie SR; Krysan DJ
mSphere; 2021 Aug; 6(4):e0053921. PubMed ID: 34406854
[TBL] [Abstract][Full Text] [Related]
15. Efficient clearance of Aspergillus fumigatus in murine lungs by an ultrashort antimicrobial lipopeptide, palmitoyl-lys-ala-DAla-lys.
Vallon-Eberhard A; Makovitzki A; Beauvais A; Latgé JP; Jung S; Shai Y
Antimicrob Agents Chemother; 2008 Sep; 52(9):3118-26. PubMed ID: 18606837
[TBL] [Abstract][Full Text] [Related]
16. Scanning Quadrupole Data-Independent Acquisition, Part B: Application to the Analysis of the Calcineurin-Interacting Proteins during Treatment of Aspergillus fumigatus with Azole and Echinocandin Antifungal Drugs.
Juvvadi PR; Moseley MA; Hughes CJ; Soderblom EJ; Lennon S; Perkins SR; Thompson JW; Geromanos SJ; Wildgoose J; Richardson K; Langridge JI; Vissers JPC; Steinbach WJ
J Proteome Res; 2018 Feb; 17(2):780-793. PubMed ID: 29251506
[TBL] [Abstract][Full Text] [Related]
17. A Fluorescence-Based High-Throughput Screening Assay to Identify Growth Inhibitors of the Pathogenic Fungus Aspergillus fumigatus.
Smith TM; Richie DL; Tao J
Methods Mol Biol; 2016; 1439():171-9. PubMed ID: 27316995
[TBL] [Abstract][Full Text] [Related]
18. The volatome of Aspergillus fumigatus.
Heddergott C; Calvo AM; Latgé JP
Eukaryot Cell; 2014 Aug; 13(8):1014-25. PubMed ID: 24906414
[TBL] [Abstract][Full Text] [Related]
19. Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis.
van der Linden JW; Arendrup MC; Melchers WJ; Verweij PE
Emerg Infect Dis; 2016 Jan; 22(1):158-9. PubMed ID: 26691166
[No Abstract] [Full Text] [Related]
20. Aspergillus fumigatus and Aspergillosis in 2019.
Latgé JP; Chamilos G
Clin Microbiol Rev; 2019 Dec; 33(1):. PubMed ID: 31722890
[No Abstract] [Full Text] [Related]
[Next] [New Search]
